메뉴 건너뛰기




Volumn 16, Issue 2, 2004, Pages 109-111

Modelling tacrolimus AUC in acute and chronic liver disease immediately after transplant

Author keywords

Acute and chronic liver disease; AUC prediction; Tacrolimus

Indexed keywords

ALBUMIN; ASPARTATE AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; UREA;

EID: 4344606296     PISSN: 09469648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)

References (10)
  • 1
    • 0142166695 scopus 로고    scopus 로고
    • Timeline: Individuality: The barrier to optimal immunosuppression
    • Kahan BD (2003) Timeline: Individuality: the barrier to optimal immunosuppression. Nat Rev Immunol 3 (10): 831-8
    • (2003) Nat Rev Immunol , vol.3 , Issue.10 , pp. 831-838
    • Kahan, B.D.1
  • 2
    • 0038684549 scopus 로고    scopus 로고
    • Pharmacokinetics of tacrolimus-based combination therapies
    • Undre NA (2003) Pharmacokinetics of tacrolimus-based combination therapies. Nephrol Dial Transplant 18 (Suppl. I): i12-5
    • (2003) Nephrol Dial Transplant , vol.18 , Issue.SUPPL. I
    • Undre, N.A.1
  • 4
    • 0037319247 scopus 로고    scopus 로고
    • Toward better outcomes with tacrolimus therapy: Population pharmacokinetics and individualized dosage prediction in adult liver transplantation
    • Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE (2003) Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Liver Transpl 9 (2): 130-7
    • (2003) Liver Transpl , vol.9 , Issue.2 , pp. 130-137
    • Staatz, C.E.1    Willis, C.2    Taylor, P.J.3    Lynch, S.V.4    Tett, S.E.5
  • 5
    • 0034533161 scopus 로고    scopus 로고
    • In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation
    • Tolou-Ghamari Z, Wendon J, Tredger JM (2000) In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation. Clinical Chemistry and Laboratory Medicine 38 (11): 1209-11
    • (2000) Clinical Chemistry and Laboratory Medicine , vol.38 , Issue.11 , pp. 1209-1211
    • Tolou-Ghamari, Z.1    Wendon, J.2    Tredger, J.M.3
  • 6
    • 0027956083 scopus 로고
    • Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK506 and cyclosporin in liver transplant recipients
    • Cakaloglu Y, Tredger JM, Devlin J, Williams R (1994) Importance of cytochrome P-450IIIA activity in determining dosage and blood levels of FK506 and cyclosporin in liver transplant recipients. Hepatology 20: 309-15
    • (1994) Hepatology , vol.20 , pp. 309-315
    • Cakaloglu, Y.1    Tredger, J.M.2    Devlin, J.3    Williams, R.4
  • 7
    • 0028848557 scopus 로고
    • Using cyclosporin Neoral immediately after liver transplantation
    • United Kingdom Neoral Pilot Study Group
    • Tredger JM (1995) Using cyclosporin Neoral immediately after liver transplantation. United Kingdom Neoral Pilot Study Group. Ther Drug Monit 17: 638-41
    • (1995) Ther Drug Monit , vol.17 , pp. 638-641
    • Tredger, J.M.1
  • 9
    • 0031832692 scopus 로고    scopus 로고
    • Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients
    • Christiaans M, van-Duijnhoven E, Beysens T, Undre N, Schafer A, van-Hooff J (1998) Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients. Transplant Proc 30: 1271-3
    • (1998) Transplant Proc , vol.30 , pp. 1271-1273
    • Christiaans, M.1    Van-Duijnhoven, E.2    Beysens, T.3    Undre, N.4    Schafer, A.5    Van-Hooff, J.6
  • 10
    • 1042304276 scopus 로고    scopus 로고
    • Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay
    • Tolou-Ghamari Z, Palizban AA, Tredger JM (2004) Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay. Drugs in Research and Development 5 (1): 17-22
    • (2004) Drugs in Research and Development , vol.5 , Issue.1 , pp. 17-22
    • Tolou-Ghamari, Z.1    Palizban, A.A.2    Tredger, J.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.